NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 59 filers reported holding NEON THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,893,000 | -26.6% | 399,308 | 0.0% | 0.06% | -44.4% |
| Q1 2019 | $2,580,000 | +28.4% | 399,308 | 0.0% | 0.11% | -28.0% |
| Q4 2018 | $2,009,000 | -67.0% | 399,308 | -43.9% | 0.15% | -7.4% |
| Q3 2018 | $6,079,000 | -32.2% | 711,808 | -0.0% | 0.16% | +5.9% |
| Q2 2018 | $8,969,000 | – | 711,809 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 9,741,636 | $46,175,000 | 19.63% |
| Endurant Capital Management LP | 465,650 | $2,207,000 | 0.87% |
| HARVARD MANAGEMENT CO INC | 505,871 | $2,398,000 | 0.59% |
| Partner Investment Management, L.P. | 103,596 | $491,000 | 0.52% |
| MEITAV INVESTMENT HOUSE LTD | 639,465 | $3,002,000 | 0.20% |
| Hillhouse Capital Management | 399,308 | $1,893,000 | 0.06% |
| ArrowMark Colorado Holdings LLC | 703,375 | $3,334,000 | 0.03% |
| PFM Health Sciences, LP | 121,848 | $578,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,200 | $755,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 77,024 | $365,000 | 0.01% |